Decisive decrease not yet visible Decisive effects from the lockdown of 15 December have yet to be seen. Although there was a decrease in the number of people who were tested and the number of people who tested positive for COVID-19.
Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.
Long-term disruption of day/night rhythms increases risk of breast cancer and leads to gain in bodyweight Long-term disruption of day/night rhythms leads to an increase in breast cancer risk and bodyweight in mice susceptible to breast cancer.
High number of tick bites expected this summer It is expected that over the coming month, around half a million people will be bitten by a tick. Last month, considerably more tick bites have been reported compared to previous years.
Gardner Middlebrook Award 2015 to Dick van Soolingen RIVM congratulates Professor Dick van Soolingen, who was presented the highly coveted Gardner Middlebrook Award.
Annual report RIVM 2014 online In our annual report, we look back at compelling RIVM projects and research in 2014.
Marc Bonten appointed as new top scientist at RIVM On 1 July, Prof. Dr Marc Bonten, Clinical Microbiologist, took office as a top academic staff member at the RIVM Centre for Infectious Disease Control.
National Heat Plan active The National Heat Plan became active in the Netherlands on June 30th. This means that it is necessary to take preventive health measures for vulnerable groups.
Risk of degradation of European ecosystems by air pollution is decreasing The number of natural areas in Europe that are threatened by air pollution will decrease between 2005 and 2020.
RIVM participates in large EU project to head up global fight against infectious diseases COMPARE, a large EU project intends to speed up the detection of, and response to disease outbreaks among humans and animals worldwide, through the use of new genome technology.